Parabilis Medicines, Inc.

PBLS

Held by 7 specialist biotech funds

High ConvergenceHigh short interest · No specialist buying

7 funds opened new positions. Short interest: 4.3% of float.

Share

Signal Score

5.5/10

7 funds opened new positions●●

No recent insider activity●●

No upcoming catalysts●●

Held by 7 specialist funds●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

7 fund convergence

Driehaus CapitalNew

Deerfield ManagementNew

Casdin CapitalNew

Rock Springs CapitalNew

Baker Bros. AdvisorsNew

RA Capital ManagementNew

Cormorant Asset ManagementNew

Short Interest

High short interestSI rising 4 periods (+370.8%)

Short Shares

5.26M

Change

+32.9%

Days to Cover

13.7

% of Float

4.3%

Settlement

Aug 14, 2026

Short interest over 5 periods

Catalysts

No catalysts tracked.

Be first to know when this name moves

Fund buys and exits, insider activity, and catalyst alerts across 800+ biotechs — free Monday brief.

Activist Filings

SC 13DRA Capital Management23.8%Jun 18, 2026

Position Details

Driehaus CapitalNEW POSITIONAug 14, 2026

Start free trialfor share counts, dollar values & AI analysis

6 more position changes — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Also Held by These Funds

IDYA1 fund IMTX1 fund IMNM1 fund IMVT1 fund INCY1 fund CRNX1 fund CYTK1 fund MIRM1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts:

Terms

Privacy

Disclaimer